首页|期刊导航|中国中医骨伤科杂志|苍柏丹防治骨科术后下肢深静脉血栓形成及炎症反应的实验研究

苍柏丹防治骨科术后下肢深静脉血栓形成及炎症反应的实验研究OA

Experimental Study on the Efficacy of Cangbai Dan in Treating Lower Extremity Deep Venous Thrombosis and Inflammatory Response after Orthopedic Surgery

中文摘要英文摘要

目的:探讨苍柏丹对骨科大手术后下肢深静脉血栓形成及炎症的影响.方法:将50只大鼠随机分为空白组、模型组、苍柏丹低/高剂量组和阳性药物组,每组各10只,空白组正常喂养.除空白组外各组进行骨科大手术后大鼠下肢深静脉血栓模型造模,造模5 d后模型组和空白组大鼠开始生理盐水灌胃2次(2.5 mL/次),生理盐水0.3 mL皮下注射1次;苍柏丹低剂量组大鼠临床1倍剂量中药(6.84 g/kg)灌胃2次,生理盐水0.3 mL 皮下注射1次;苍柏丹高剂量组大鼠临床2倍剂量中药(13.68 g/kg)灌胃2次,生理盐水0.3 mL皮下注射1次;阳性药物组大鼠生理盐水灌胃2次(2.5 mL/次),低分子肝素钙注射液0.3 mL皮下注射1次.连续用药5 d,取大鼠大隐静脉1~2 cm石蜡包埋切片,苏木精-伊红(HE)染色法、免疫组化和 Western Blot法检测各组血管内皮细胞内人核因子κB抑制蛋白α(NF-κB Inhibitor α,IκBα)和p65蛋白表达;腹主动脉采血用酶联免疫吸附测定法(ELISA)检测血浆白细胞介素(IL)-6、IL-8、高迁移率族蛋白B1(HMGB1)浓度.结果:大隐静脉HE染色可见苍柏丹和阳性药物对血管内膜发挥保护作用,高剂量组保护效果更好.ELISA检测各组大鼠血清IL-6、IL-8、HMGB1的表达水平,差异有统计学意义(P<0.05);空白组<阳性药物组,苍柏丹高剂量组<苍柏丹低剂量组<模型组,苍柏丹高剂量组与阳性药物组比较差异无统计学意义(P>0.05).Western Blot法检测IκBα和p65的蛋白表达:空白组<阳性药物组,苍柏丹高剂量组<苍柏丹低剂量组<模型组,差异有统计学意义(P<0.05);苍柏丹高剂量组与阳性药物组比较差异无统计学意义(P>0.05).免疫组化法检测IκBα和p65的蛋白表达:空白组<阳性药物组,苍柏丹高剂量组<苍柏丹低剂量组<模型组,差异有统计学意义(P<0.05);苍柏丹高剂量组与阳性药物组比较差异无统计学意义(P>0.05).结论:苍柏丹发挥其清热祛湿、活血祛瘀的功效,通过抑制NF-κB通路的异常活化,调控NF-κB p65、IκBα的mRNA和蛋白表达,进而有效抑制炎症反应,从而治疗下肢深静脉血栓形成.

Objective:To evaluate the effects of Cangbai Dan on deep vein thrombosis(DVT)formation and inflammation after major orthopedic surgery.Methods:Fifty rats were ran-domly assigned to five groups(n=10 each):blank,model,low-dose Cangbai Dan,high-dose Cangbai Dan,and positive drug group.Except for the blank group,all rats underwent DVT modeling.From day 5 post-surgery,rats received intra-gastric administration of Cangbai Dan(6.84 g/kg or 13.68 g/kg,twice daily),saline(2.5 mL,twice daily),or saline com-bined with low-molecular-weight heparin calcium(0.3 mL,subcutaneously,once daily)for five consecutive days.His-topathological changes in the great saphenous vein were evaluated by hematoxylin-eosin(HE)staining.Expression of IκBα and p65 proteins was assessed by immunohistochemistry and Western Blot.Serum IL-6,IL-8,and HMGB1 levels were measured by ELISA.Results:HE staining showed that Cangbai Dan and the positive drug protected the vascular endotheli-um,with superior effects in the high-dose group.ELISA demonstrated that IL-6,IL-8,and HMGB1 levels were lowest in the blank group and highest in the model group,with dose-dependent reductions in the Cangbai Dan groups.No significant difference was observed between the high-dose Cangbai Dan group and the positive drug group(P>0.05).Western Blot and immunohistochemistry showed consistent trends in IκBα and p65 expression.Conclusion:Cangbai Dan prevents post-operative lower limb DVT by inhibiting NF-κB pathway activation,downregulating NF-κB p65 and IκBα expression,and attenuating inflammatory responses.These findings support its therapeutic potential in the prevention of thrombosis after orthopedic surgery.

吴进;邱礼国;郭体康;唐勇;许晓彤;卢敏;邝高艳;谭开云

湖南中医药大学第一附属医院(长沙,410007)||湖南中医药大学湖南中医药大学第一附属医院(长沙,410007)||湖南中医药大学湖南中医药大学第一附属医院(长沙,410007)||湖南中医药大学湖南中医药大学第一附属医院(长沙,410007)||湖南中医药大学湖南中医药大学第一附属医院(长沙,410007)湖南中医药大学第一附属医院(长沙,410007)湖南中医药大学第一附属医院(长沙,410007)湖南中医药大学第一附属医院(长沙,410007)

医药卫生

苍柏丹骨科大手术下肢深静脉血栓炎症高迁移率族蛋白

Cangbai Danmajor orthopedic surgerylower extremity deep vein thrombosisinflammationhigh-mobility group histones

《中国中医骨伤科杂志》 2026 (3)

1-6,6

国家自然科学基金项目(82274543)湖南省自然科学基金项目(2023JJ30471)湖南省中医药管理局项目(B2024046,D2024042)湖南省教育厅优秀青年项目(24B0372)湖南省卫计委课题(202204074679)湖南省科技创新类湖湘青年英才项目(2024RC3203)

10.20085/j.cnki.issn1005-0205.260301

评论